Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers

Journal of Clinical Microbiology

Volumn 35, Issue 8, 1997, Pages 2055-2060

  Segonds, Christine ^a   Bingen, Edouard ^b   Couetdic, Gerard ^c   Mathy, Stephanie ^b   Brahimi, Naima ^b   Marty, Nicole ^a   Plesiat, Patrick ^c   Michel Briand, Yvon ^c   Chabanon, Gerard ^a  

^a CHU RANGUEIL   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIAL PNEUMONIA; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; FRANCE; GENE ISOLATION; GENOTYPE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA;

EID: 0030856615     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.8.2055-2060.1997     Document Type: Article

References (42)

1. Anderson, D. J., J. S. Kuhns, M. L. Vasil, D. N. Gerding, and E. N. Janoff. 1991. DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J. Clin. Microbiol. 29:648-649.
2. Barsomian, G., and T. G. Lessie. 1986. Replicon fusions promoted by insertion sequences on Pseudomonas cepacia plasmid pTGL6. Mol. Gen. Genet. 204:273-280.
3. Bingen, E. H., M. Weber, J. Derelle, N. Brahimi, N. Y. Lambert-Zechovsky, M. Vidailhet, J. Navarro, and J. Elion. 1993. Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients. J. Clin. Microbiol. 31:2589-2593.
4. Butler, S. L., C. J. Doherty, J. E. Hughes, J. W. Nelson, and J. R. W. Govan. 1995. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J. Clin. Microbiol. 33:1001-1004.
5. Cheng, H.-P., and T. G. Lessie. 1994. Multiple replicons constituting the genome of Pseudomonas cepacia 17616. J. Bacteriol. 176:4034-4042.
6. Christenson, J. C., D. F. Welch, G. Mukwaya, M. J. Muszynski, R. E. Weaver, and D. J. Brenner. 1989. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J. Clin. Microbiol. 27:270-273.
7. Cimolai, N., and C. Trombley. 1996. Enterobacterial intergenic consensus sequence polymerase chain reaction as a typing method for Burkholderia (Pseudomonas) cepacia. Clin. Microbiol. Infect. 2:59-62.
8. Dasen, S. E., J. J. LiPuma, J. R. Kostman, and T. L. Stull. 1994. Characterization of PCR-ribotyping for Burkholderia (Pseudomonas) cepacia. J. Clin. Microbiol. 32:2422-2424.
9. Fisher, M. C., J. J. LiPuma, S. E. Dasen, G. C. Caputo, J. E. Mortensen, K. L. McGowan, and T. L. Stull. 1993. Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment. J. Pediatr. 123:745-747.
10. Godard, C., P. L. Plesiat, and Y. Michel-Briand. 1993. Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months. Eur. J. Med. 2:117-120.
11. Goldstein, R., L. Sun, R.-Z. Jiang, U. Sajjan, J. F. Forstner, and C. Campanelli. 1995. Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J. Bacteriol. 177:1039-1052.
12. Govan, J. R., P. H. Brown, J. Maddison, C. J. Doherty, J. W. Nelson, M. Dodd, A. P. Greening, and A. K. Webb. 1993. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19.
13. Govan, J. R. W., J. E. Hughes, and P. Vandamme. 1996. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:395-407.
14. Isles, A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming, and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206-210.
15. Johnson, W. M., S. D. Tyler, and K. R. Rozee. 1994. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J. Clin. Microbiol. 32:924-930.
16. Kiska, D. L., A. Kerr, M. C. Jones, J. A. Caracciolo, B. Eskridge, M. Jordan, S. Miller, D. Hughes, N. King, and P. H. Gilligan. 1996. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:886-891.
17. Kostman, J. R., T. D. Edlind, J. J. LiPuma, and T. L. Stull. 1992. Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J. Clin. Microbiol. 30:2084-2087.
18. Larsen, G. Y., T. L. Stull, and J. L. Burns. 1993. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J. Clin. Microbiol. 31:788-792.
19. Lewin, L. O., P. J. Byard, and P. B. Davis. 1990. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J. Clin. Epidemiol. 43:125-131.
20. LiPuma, J. J., M. C. Fisher, S. E. Dasen, J. E. Mortensen, and T. L. Stull. 1991. Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia. J. Infect. Dis. 164:133-136.
21. LiPuma, J. J., J. E. Mortensen, S. E. Dasen, T. D. Edlind, D. V. Schidlow, J. L. Burns, and T. L. Stull. 1988. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J. Pediatr. 113:859-862.
22. Liu, P. Y.-F., Z.-Y. Shi, Y.-J. Lau, B.-S. Hu, J.-M. Shyr, W.-S. Tsai, Y.-H. Lin, and C.-Y. Tseng. 1995. Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates. J. Clin. Microbiol. 33:3304-3307.
23. Mahenthiralingam, E., M. E. Campbell, D. A. Henry, and D. P. Speert. 1996. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J. Clin. Microbiol. 34:2914-2920.
24. Millar-Jones, L., A. Paull, Z. Saunders, and M. C. Goodchild. 1992. Transmission of Pseudomonas cepacia among cystic fibrosis patients. Lancet 340: 1944. (Letter.)
25. Ouchi, K., M. Abe, M. Karita, T. Oguri, J. Igari, and T. Nakazawa. 1995. Analysis of strains of Burkholderia (Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing. J. Clin. Microbiol. 33:2353-2357.
26. Pitt, T. L., M. E. Kaufman, P. S. Patel, L. C. A. Benge, S. Gaskin, and D. M. Livermore. 1996. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J. Med. Microbiol. 44: 203-210.
27. Rabkin, C. S., W. R. Jarvis, R. L. Anderson, J. Govan, J. Klinger, J. LiPuma, W. J. Martone, H. Monteil, C. Richard, S. Shigeta, A. Sosa, T. Stull, J. Swenson, and D. Woods. 1989. Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev. Infect. Dis. 11:600-607.
28. Rodley, P. D., U. Römling, and B. Tümmler. 1995. A physical genome map of the Burkholderia cepacia type strain. Mol. Microbiol. 17:57-67.
29. Sajjan, U. S., L. Sun, R. Goldstein, and J. F. Forstner. 1995. Cable (Cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J. Bacteriol. 177:1030-1038.
30. Segonds, C., and G. Chabanon. 1997. Caractérisation des espèces du genre Burkholderia par analyse du polymorphisme de restriction (RFLP) de l'ADNr16S amplifié par PCR: intérêt diagnostique chez les patients atteints de mucoviscidose. In Program and abstracts of the 31st January 1997 SFM Conference on Pseudomonas and Related Bacteria. Société Française de Microbiologie, Paris, France.
31. Segonds, C., G. Chabanon, G. Couetdic, Y. Michel-Briand, and E. Bingen. 1996. Epidemiology of pulmonary colonization with Burkholderia cepacia in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 15:841-842.
32. Simpson, I. N., J. Finlay, D. J. Winstaley, N. Dewhurst, J. W. Nelson, S. L. Butler, and J. R. W. Govan. 1994. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis. J. Antimicrob. Chemother. 34:353-361.
33. Smith, D. L., L. B. Gumery, E. G. Smith, D. E. Stableforth, M. E. Kaufmann, and T. L. Pitt. 1993. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J. Clin. Microbiol. 31:3017-3022.
34. Smyth, A., D. Heaf, J. Corkill, T. Hart, P. Sisson, and R. Freeman. 1993. Transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:434-435. (Letter.)
35. Steinbach, S., L. Sun, R. Jiang, P. Flume, P. Gilligan, T. M. Egan, and R. Goldstein. 1994. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fihrosis. N. Engl. J. Med. 331:981-987.
36. Struelens, M. J., and Members of the European Study Group on Epidemiological Markers of the European Society for Clinical Microbiology and Infectious Diseases. 1996. Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems. Clin. Microbiol. Infect. 2:2-11.
37. Sun, L., R. Z. Jiang, S. Steinbach, A. Holmes, C. Campanelli, J. Forstner, Y. Tan, M. Riley, and R. Goldstein. 1995. The emergence of a highly transmissible lincase of cbl+ Pseudoimmus (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nature Med. 1:661-666.
38. Tablan, O., W. Martone, and W. Jarvis. 1987. The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis. Eur. J. Epidemiol. 3:336-342.
39. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
40. Tyler, S. D., K. R. Rozee, and W. M. Johnson. 1996. Identification of IS1356, a new insertion sequence, and its association with IS402 in epidemic strains of Burkholderia cepacia infecting cystic fibrosis patients. J. Clin. Microbiol. 34:1610-1616.
41. van Belkum, A., J. Kluytmans, W. van Leeuwen, R. Bax, W. Quint, E. Peters, A. Fluit, C. Vandenbroucke-Grauls, A. van den Brule, H. Koeleman, W. Melchers, J. Meis, A. Elaichouni, M. Vaneechoutte, F. Moonens, N. Maes, M. Struelens, F. Tenover, and H. Verbrugh. 1995. Multicenter evaluation of arbitrarily primed PCR for typing of Staphylococcus aureus strains. J. Clin. Microbiol. 33:1537-1547.
42. Wood, M. S., C. Lory, and T. G. Lessie. 1990. Activation of the lac genes of Tn951 by insertion sequences from Pseudomonus cepacia. J. Bacteriol. 172: 1719-1724.